Dr. Juan Zarate, MD
What this data tells you about Dr. Zarate
Dr. Juan Zarate is a cardiovascular disease in Crestview, FL, with 20 years in practice. Based on federal Medicare data, Dr. Zarate performed 10,066 Medicare services across 6,867 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zarate received a total of $5,638 from 26 pharmaceutical and/or device companies across 206 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zarate is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,757 | $91 | $191 |
| Electrocardiogram (EKG), 12-lead | 831 | $10 | $46 |
| Echocardiogram, transthoracic | 809 | $70 | $321 |
| Regadenoson injection (Lexiscan) for heart stress test | 688 | $45 | $92 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 481 | $20 | $50 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 479 | $28 | $91 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 422 | $222 | $288 |
| Hospital follow-up visit, moderate complexity | 332 | $61 | $128 |
| Remote pacemaker/defibrillator monitoring, 90 days | 295 | $17 | $60 |
| EKG interpretation and report | 263 | $6 | $25 |
| Prothrombin time test (blood clotting) | 250 | $4 | $21 |
| Remote pacemaker monitoring, 90 days | 228 | $23 | $65 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 211 | $324 | $859 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 172 | $64 | $181 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 169 | $20 | $47 |
| Initial hospital admission, moderate complexity | 152 | $102 | $246 |
| New patient office visit (45-59 min) | 148 | $121 | $291 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 144 | $10 | $40 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 129 | $50 | $275 |
| Programming of dual lead pacemaker system | 122 | $60 | $124 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 114 | $14 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 95 | $16 | $43 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 95 | $26 | $113 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 71 | $29 | $121 |
| Cardiac catheterization | 68 | $210 | $606 |
| Electrocardiogram (ecg) 2-day continuous | 67 | $13 | $70 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 67 | $14 | $47 |
| Lipid panel (cholesterol and triglycerides) | 60 | $13 | $34 |
| External shock to heart to regulate heart beat | 37 | $85 | $400 |
| Ultrasound of heart, follow-up | 31 | $29 | $88 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 31 | $8 | $42 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 30 | $6 | $42 |
| Office visit, established patient (20-29 min) | 25 | $65 | $130 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 21 | $624 | $1,481 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 20 | $18 | $45 |
| Programming of dual lead implantable defibrillator system | 20 | $41 | $154 |
| Programming of multiple lead implantable defibrillator system | 19 | $82 | $176 |
| Programming of single lead pacemaker system | 18 | $52 | $102 |
| Ultrasound of both sides of head and neck blood flow | 18 | $124 | $420 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $83 | $194 |
| Ultrasound of leg arteries or artery grafts | 14 | $180 | $504 |
| Insertion of heart rhythm monitor under skin | 12 | $72 | $400 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 12 | $5 | $41 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 12 | $16 | $48 |
| Complete ultrasound study of arm and leg arteries | 11 | $92 | $324 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Zarate is a cardiac & remote specialist, with above-average Medicare volume (top 8% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Zarate experienced with office visit, established patient (30-39 min)?
Does Dr. Zarate receive payments from pharmaceutical companies?
How do Dr. Zarate's costs compare to other cardiovascular diseases in Crestview?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology